West declares third quarter dividend of $0.17 per share

NewsGuard 100/100 Score
Editorial Checklist Reviewed
May 7 2011West Pharmaceutical Services, Inc.

West Pharmaceutical Services, Inc. (NYSE: WST) today announced that its Board of Directors has approved payment of the third-quarter 2011 cash dividend of $0.17 per share. The dividend will be paid on August 3, 2011 to shareholders of record on July 20, 2011.

In addition, West announced that its shareholders approved each of the proposals presented at its May 3, 2011 annual meeting, as recommended by its Board of Directors.  These included a proposal to declassify the Board and, as a result, each of the Company's directors will be elected annually beginning in 2012.

Source:

West Pharmaceutical Services, Inc.

Posted in: Business / Finance

Tags: ,

Comments (0)

Suggested Reading

Natural obesity fighters: How coffee, tea, and cocoa combat weight gain
LabVantage celebrates customer success with record number of software deployments in FY 2024
SickKids study offers new path for pediatric rare disease clinical trials
MD Anderson acquires cell therapy safety technology from Bellicum Pharmaceuticals
Study highlights global fertility decline and its implications for the future
Pembrolizumab enhances breast cancer treatment regardless of age or menopausal status
Croatian sea fennel may contain a treasure trove of preservative and anti-aging metabolites
Lancet Commission predicts sharp increase in global prostate cancer cases

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
(Logout)
Post

Newsletters you may be interested in

See all Newsletters »

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback

You might also like...
The Lancet Breast Cancer Commission: Tackling inequalities, hidden costs, and empowering patients